US Patent 10617707 Oligonucleotides to treat eye disease
Patent 10617707 was granted and assigned to ProQR Therapeutics on April, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10617707 Oligonucleotides to treat eye disease
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10617707
Date of patent
April 14, 2020
Patent application number
16096038
Date Filed
April 25, 2017
Patent primary examiner
Find more entities like US Patent 10617707 Oligonucleotides to treat eye disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.